https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depression
0
0
8/4/23 at 10:48pm
Organization
FDA.gov
Author
Office of the Commissioner
27 words
0
Comments
The FDA approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.
You are the first to view
Create an account
or login to join the discussion